Periodic Reporting for period 1 - PLENITUDE (First-of-its-kind, large-scale, lowest-cost, zero-waste biorefinery for the production of proteins for food and feed application from low cost sustainable feedstocks.)
Période du rapport: 2019-10-01 au 2021-03-31
PLENITUDE addresses the protein challenge by integrating two established processes into a flagship, large-scale, first-of-its-kind, biorefinery producing bioethanol and sustainable food protein in an integrated process.
PLENITUDE brings together 10 key players in the bioeconomy spanning 5 EU member states and representing every link in the value chain. This includes expertise in primary processing and industrial operations (Cargill), biotechnology (3F BIO Limited), product development and applications (International Flavors & Fragrances I.F.F. B.V) primary research and protein expertise (Wageningen University) a specialist consultants covering marketing and sustainability (Bridge 2 Food, Life Cycle Engineering Srl), and three end-users covering food categories (Mosa Meat, Vivera, ABP) as well as one end-user covering bio-plastics (Lactips).
The global consumption of “meat” protein currently totals around 500 million tonnes per year, with less than 1% derived from non-animal sources. Experts including the Food and Agriculture Organization of the United Nations (FAO) predict that the demand for non-animal proteins may increase to account for 10-20% of the growing total demand, which would create a need for 100-200 million tonnes of plant protein by 2050.
With initial output capacity of 16k tonnes per annum, this flagship project will increase the availability of sustainable, high-quality food protein. The collaboration between the biorefinery operator, food producers and technology providers will create new cross-sector interconnections, new bio-based value chains, and new bio-based ‘consumer’ products.
The project includes a full assessment of the environmental, economic, health and social impacts of the developed products or processes, using LCA/LCC/S-LCA methodologies based on available standards to validate the sustainability and food safety of the products and value chain. Based on a target to produce 1 million tonnes of protein by 2030, it is estimated that this could equate to a reduction of >5 million tonnes of carbon emissions.
PLENITUDE brings together 10 key players in the bioeconomy spanning 5 EU member states and representing every link in the value chain. This includes expertise in primary processing and industrial operations (Cargill), biotechnology (3F BIO Limited), product development and applications (International Flavors & Fragrances I.F.F. B.V) primary research and protein expertise (Wageningen University) a specialist consultants covering marketing and sustainability (Bridge 2 Food, Life Cycle Engineering Srl), and three end-users covering food categories (Mosa Meat, Vivera, ABP) as well as one end-user covering bio-plastics (Lactips).
The global consumption of “meat” protein currently totals around 500 million tonnes per year, with less than 1% derived from non-animal sources. Experts including the Food and Agriculture Organization of the United Nations (FAO) predict that the demand for non-animal proteins may increase to account for 10-20% of the growing total demand, which would create a need for 100-200 million tonnes of plant protein by 2050.
With initial output capacity of 16k tonnes per annum, this flagship project will increase the availability of sustainable, high-quality food protein. The collaboration between the biorefinery operator, food producers and technology providers will create new cross-sector interconnections, new bio-based value chains, and new bio-based ‘consumer’ products.
The project includes a full assessment of the environmental, economic, health and social impacts of the developed products or processes, using LCA/LCC/S-LCA methodologies based on available standards to validate the sustainability and food safety of the products and value chain. Based on a target to produce 1 million tonnes of protein by 2030, it is estimated that this could equate to a reduction of >5 million tonnes of carbon emissions.
The reporting period covers 18 months from October 2019 though to March 2021. The activities in all workstreams are substantially on track even though the plan has been adapted following a change in the constituents of the consortium and an adaptation of the implementation plan.
During this period, amendments were agreed with BBI JU:
AMD-838104-5 Amendment to change the consortium following withdrawal of Alcogroup. Initiated 15 November 2020 and agreed 08 Feb 2021
AMD-838104-7 Amendment to change the term to 66 months from 60 months. Initiated 09 February 2021 and agreed 22 Feb 2021
There was one milestone (MS1) due in the period and this was completed successfully and on time. The main work packages that were active during this period were:
WP 2 Technology Development
This work package has been completed with an agreed C19 extension from M7 to M9.
Due to the change in the consortium, and the resultant change in location for the flagship plant (moving from Rotterdam to Sas van Gent) some of the work was reworked.
WP 3 Flagship Plant construction
The activities for this WP are all in progress and most notably at this stage relate to the permit approval and the engineering contracting which will support meeting Milestones 3,4,5 and 6, all of which are due in the next 18-month period
WP 5 Characterisation of Inputs & Outputs
Activities underway and on track. In order to build some wider consortium momentum with agreement this WP started in M4 rather than original M13.
WP 6 Exploitation and Commercialisation
Activities underway and on track with involvement from demand partners.
WP 7 Dissemination and Communications.
All activities on track
WP 9 Project Management
Systems and processes on track. Included consortium communication during suspension period.
During this period, amendments were agreed with BBI JU:
AMD-838104-5 Amendment to change the consortium following withdrawal of Alcogroup. Initiated 15 November 2020 and agreed 08 Feb 2021
AMD-838104-7 Amendment to change the term to 66 months from 60 months. Initiated 09 February 2021 and agreed 22 Feb 2021
There was one milestone (MS1) due in the period and this was completed successfully and on time. The main work packages that were active during this period were:
WP 2 Technology Development
This work package has been completed with an agreed C19 extension from M7 to M9.
Due to the change in the consortium, and the resultant change in location for the flagship plant (moving from Rotterdam to Sas van Gent) some of the work was reworked.
WP 3 Flagship Plant construction
The activities for this WP are all in progress and most notably at this stage relate to the permit approval and the engineering contracting which will support meeting Milestones 3,4,5 and 6, all of which are due in the next 18-month period
WP 5 Characterisation of Inputs & Outputs
Activities underway and on track. In order to build some wider consortium momentum with agreement this WP started in M4 rather than original M13.
WP 6 Exploitation and Commercialisation
Activities underway and on track with involvement from demand partners.
WP 7 Dissemination and Communications.
All activities on track
WP 9 Project Management
Systems and processes on track. Included consortium communication during suspension period.
Creation of 4 new cross sector connections biorefineries, food, mycoprotein and pet food.
Creation of 3 new value chains.
Creation of 10 new products.
Reduction in carbon footprint by >20% compared with existing protein
Creation of 3 new value chains.
Creation of 10 new products.
Reduction in carbon footprint by >20% compared with existing protein